Ischemic Stroke: Prying Open the Treatment Window
Executive Summary
At this year's International Stroke Conference in San Antonio, some exciting device-based therapies and approaches were discusssed--including advanced imaging, multimodal therapy and stent-like thrombectomy devices--that may offer improved outcomes for patients that suffer an acute ischemic stroke.
You may also be interested in...
Neurointerventional Market Shows Strong Growth Potential
The neurointerventional device market is one of the most dynamic areas in the field of neurology. Over the next four years, US neurointerventional procedures are expected to grow at a rate of nearly 18% compounded annually, reaching more than 197,000 procedures by 2015. The market information in this article was compiled from Medtech Insight’s new report "US Markets for Neurosurgical and Neurointerventional Surgical Products," #A590, published March 2011.
ISC 2011: Stroke Device Innovation and Investment
At this February's International Stroke Conference held in Los Angeles, the latest advances in cerebrovascular disease diagnosis, treatment, and prevention were highlighted, including cutting-edge endovascular therapies for use in acute ischemic stroke treatment and prevention, as well as new options for more deadly hemorrhagic stroke.
Market & Industry Briefs
Brief summaries of recent medtech market and industry developments. This month we cover Covidien's acquisition of ev3, J&J's moves in the endovascular market, DePuy's launch of new products in hip revision, and FDA regulation of consumer genomics.